New patent for Abbvie Inc drug MAVYRET

   May 26, 2021    Comments Off on New patent for Abbvie Inc drug MAVYRET    Posted in: Patent Added

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are seven patents…

The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog